Obesity is associated with impaired cardiac autonomic modulation in children

Sol M Rodríguez-Colón1, Edward O Bixler, Xian Li

  • 1Department of Public Health Sciences, Penn State University College of Medicine, Hershey, PA 17033, USA.

Insights

Childhood obesity is linked to reduced heart rate variability (HRV), indicating an imbalance in cardiac autonomic modulation. Early intervention for pediatric obesity is crucial to prevent future cardiac issues.

Area of Science:

  • Pediatric cardiology
  • Autonomic nervous system function
  • Obesity research

Background:

  • Childhood obesity is a growing public health concern.
  • Cardiac autonomic modulation (CAM) plays a vital role in cardiovascular health.
  • Subclinical CAM impairment may precede overt cardiovascular disease.

Purpose of the Study:

  • To investigate the association between obesity and subclinical CAM in children.
  • To identify specific obesity metrics correlated with CAM impairment.

Main Methods:

  • Cross-sectional study of 616 children (grades K-5).
  • Obesity classified using International Obesity Task Force (IOTF) criteria.
  • Cardiac autonomic modulation assessed via heart rate variability (HRV) analysis (time and frequency domain measures).

Main Results:

  • Prevalence of overweight and obesity was 16.5% and 12.3%, respectively.
  • Obese children exhibited significantly lower standard deviation of normal-to-normal intervals (SDNN) and high frequency power (HF) compared to normal weight children.
  • Body weight was the strongest correlate of HRV indices.

Conclusions:

  • Childhood obesity is associated with impaired cardiac autonomic modulation, characterized by sympathetic nervous system dominance.
  • These findings highlight the importance of addressing pediatric obesity to mitigate cardiovascular risk.
  • Targeting childhood obesity early may prevent future cardiac events.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...